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Abstract: Multiple recent studies have demonstrated the limited utility of morphological methods used singly for species identification of clinically relevant aspergilli. It is 
being increasingly recognised that comparative sequence based methods used in conjunction with traditional phenotype based methods can offer better resolution of species 
within this genus. Recognising the growing role of molecular methods in species recognition, the recently convened international working group meeting entitled “Aspergillus 
Systematics in the Genomic Era” has proposed several recommendations that will be useful in such endeavors. Specific recommendations of this working group include the use 
of the ITS regions for inter section level identification and the β-tubulin locus for identification of individual species within the various Aspergillus sections.
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INTRODUCTION
aspergilli cause a wide spectrum of infections including cutaneous 
manifestations,  otomycosis,  and  invasive  infections  such  as 
pulmonary aspergillosis and endocarditis. Pulmonary aspergillosis 
may range from invasive pulmonary aspergillosis (IPA) in severely 
immunocompromised patients to chronic necrotising aspergillosis in 
mildly immunocompromised populations. The risk of IPA appears to 
be much higher in hematopoietic stem cell transplant patients and 
in patients with leukemia, where the attributable mortality rate was 
38.5 % according to a recent study (Pagano et al. 2007). Aspergillus 
fumigatus remains the predominant agent of IPA, followed by either 
A. terreus or A. flavus depending on the medical center. Recently, 
IPA due to A. ustus and other rare aspergilli such as A. alliaceus 
(Balajee et al. 2007), A. lentulus (Balajee et al. 2005a) and A. 
udagawae (Balajee et al. 2006) have been reported.
The genus Aspergillus was originally divided into subgenera 
and groups (Raper & Fennell 1965) but the current classification 
scheme  replaces  the  designation  “group”  with  “section”  (Gams 
et  al.  1985)  to  conform  to  rules  of  the  International  Code  of 
Botanical  Nomenclature.  Currently,  the  genus  Aspergillus  is 
classified into 7 subgenera that are in turn sub-divided into several 
sections comprised of related species (Gams et al. 1985). Clinical 
microbiology  laboratories  rely  heavily  on  morphology-based 
identification methods for Aspergillus species wherein diagnostic 
criteria include the recognition of asexual or sexual structures and 
their  characteristics  such  as  shape,  size,  color,  ornamentation 
and/or mode of attachment. Unfortunately, numerous difficulties 
exist in such a phenotype-based scheme largely because these 
characteristics  are  unstable,  and  clinical  aspergilli  sometimes 
manifest atypically with slow sporulation and aberrant conidiophore 
formation.  Additionally,  members  of  the  section  Fumigati  have 
overlapping morphological characteristics, with several genetically 
distinct species existing within a single morphospecies. 
Clinically,  identification  of  unknown  Aspergillus  clinical 
isolates to species may be important given that different species 
have variable susceptibilities to multiple antifungal drugs. Thus, 
knowledge  of  the  species  identity  may  influence  the  choice  of 
appropriate antifungal therapy. For example, in vitro and in vivo 
studies  have  demonstrated  that  A.  terreus  isolates  are  largely 
resistant to the antifungal drug amphotericin B, A. ustus isolates 
appear to be refractory to azoles, and A. lentulus and Petromyces 
alliaceus  have  low  in  vitro  susceptibilities  to  a  wide  range  of 
antifungals including amphotericin B, azoles, and echinocandins 
(Balajee et al. 2005a, 2007). Comparative DNA sequence-based 
identification formats appear to be promising in terms of speed, 
ease, objectivity and economy for species identification. Multiple 
genes ranging from the universal ribosomal DNA regions ITS and 
the large ribosomal subunit D1–D2 to protein encoding genes such 
as the β-tubulin and calmodulin gene regions have been evaluated 
to delimit species within aspergilli.
In spite of the shift of fungal identification formats into the 
molecular arena as evidenced by numerous publications, there 
is no consensus on the gene/genes that can be used for species 
identification  in the genus Aspergillus.  As a first  step,  a group 
of  experts  met  at  the  “International  Workshop  on  Aspergillus 
Systematics  in  the  Genomic  Era”  [Utrecht,  The  Netherlands; 
April 2007] and presented research data on species identification 
strategies available to identify aspergilli. Throughout the meeting, 
research pertaining to the utility of the ITS region for inter section level 
classification of Aspergillus was presented. The session “Species 
identification  in  the  clinical  setting”  was  proposed  specifically 
to deliberate on the utility of comparative sequence analyses of 
protein coding loci for intra section level species identification. This 
communication is a report of the research findings presented at this 
session. At the end of the report, we present the recommendations 
proposed by the Aspergillus working group for inter species level 
recognition of clinically relevant aspergilli and for identification of 
species within the sections Fumigati, Terrei, Usti and Emericella 
nidulans. 40
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Pathogenic species in Aspergillus section Fumigati and 
species delimitation based on polyphasic taxonomy
The most common causative agent of aspergillosis is A. fumigatus 
with  rare  reports  of  invasive  infections  caused  by  species  of 
Neosartorya. However, clinical isolates of A. fumigatus are not 
necessarily morphologically uniform, and mistaken identification 
of these taxa by morphological characteristics has occurred in the 
past. In order to develop diagnostic techniques, it is essential to 
clarify intra- and interspecies diversity in A. fumigatus and closely 
related species using robust techniques.
Recently, A. lentulus isolated from clinical specimens in the 
U.S.A. was described as a new species; members of this species 
were not able to survive at 48 °C, and this species has high in vitro 
MICs to several different classes of antifungals (Balajee et al. 2005a). 
Members of this species were distinct from the other species in this 
section, which includes the varieties of A. fumigatus. Two additional 
new species, A. fumigatiaffinis and A. novofumigatus, had also been 
proposed (Hong et al. 2005) by investigators who analyzed the 
species within the section Fumigati using a polyphasic approach 
that included phenotypic characters such as macro- and micro-
morphology, growth temperature regimes, and extrolite patterns, 
and  genotypic  characters  including  RAPD-PCR  and  multi-locus 
sequence typing (MLST) of partial β-tubulin, calmodulin and actin 
genes. From these results, 30 species were accepted within the 
section Fumigati (Hong et al. 2006) and their taxonomic positions 
are shown in Fig. 1. Although A. fumigatus is the predominant 
agent of aspergillosis, several species in the section have also 
been reported from clinical samples: A. fumisynnematus (Yaguchi 
et al. 2007), A. lentulus (Balajee et al. 2005), A. viridinutans species 
complex (Hong et al. 2005, 2006; Katz et al. 2005), Neosartorya 
coreana (Hong et al. 2006; Katz et al. 2005), N fennelliae ((Kwon-
Chung & Kim 1974), N. fischeri (Chim et al. 1998; Gori et al. 1998), 
N. pseudofischeri (often as the anamorph A. thermomutans status) 
(Balajee et al. 2005b; Coriglione et al. 1990; Padhye et al. 1994), N. 
spinosa (Summerbell et al. 1992; Gerber et al. 1973), N. hiratsukae 
(Guarro et al. 2002) and N. udagawae (Balajee et al. 2006). In the 
case of N. coreana and N. fennelliae, pathogenicity in humans has 
not been established yet.
Because of the re-evaluation of section Fumigati based on 
polyphasic methods, the molecular identification of the A. fumigatus 
isolates recovered as causative agents of mycosis in humans and 
animals at the Medical Mycology Research Center, Chiba University, 
Japan (MMRC) was investigated (Yaguchi et al. 2007). Several 
other species within the section Fumigati were also included in 
the analyses. The phylogenetic relationships among A. fumigatus 
and related species, including Neosartorya species, were analyzed 
by sequencing partial regions of the β-tubulin, hydrophobin and 
calmodulin genes. The gene regions were sequenced directly from 
the PCR products by using primer pairs Bt2a and Bt2b, rodA1 and 
rodA2,  and  cmd5  and  cmd6,  respectively.  PCR  products  were 
sequenced with the BigDye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems) on an ABI PRISM 3130 Genetic 
Analyzer (Applied Biosystems) and phylogenetic analyses were 
performed by the maximum parsimony (MP) and Neighbour-joining 
(NJ) methods. Comparative analyses of tree topologies from MP 
and NJ analyses showed no differences, and the three trees based 
on the three loci were similar. 
Results of this study showed that the species within the section 
Fumigati could be divided into five clades: clade I, typical strains of 
A. fumigatus including A. fumigatus var. ellipticus (Raper & Fennell 
1965) and A. arvii (Aho et al. 1994); clade II, species including 
A. lentulus and A. fumisynnematus (Horie et al. 1993); clade III, 
species including A. fumigatiaffinis and A. novofumigatus; clade IV, 
atypical strains of A. fumigatus including A. viridinutans Katz et al. 
1998; Varga et al. 2000); and clade V, species including A. brevipes, 
A. duricaulis and A. unilateralis. Most of the examined strains from 
clinical specimens in Japan clustered together in clade I. The other 
strains from clinical specimens fell into clades II and IV, and none of 
the clinical isolates clustered within clades III and V. 
Correlations among morphology, maximal growth temperatures, 
minimal inhibitory concentrations (MICs) of antifungal agents, and 
phylogeny of isolates within the section Fumigati were also analyzed 
(Fig. 2). Scanning electron microscopy examination of these isolates 
showed that the conidial ornamentations of isolates belonging to 
clades I and V were lobate-reticulate (Kozakiewicz 1989), while 
those of A. viridinutans were intermediate between lobate-reticulate 
and microtuberculate. All strains in clade II and the six variant 
isolates in clade IV (IFM 5058, 51744, 53867, 53868, 54302 and 
CBM FD-0143) had conidia with microtuberculate ornamentation. 
These six strains are very closely related to N. udagawae (Horie 
et al. 1995), a heterothallic species isolated from soil in Brazil. 
However, mating between these strains and N. udagawae did not 
occur. It is often difficult to perform successful mating experiments 
on clinical isolates and fungi that have been routinely sub-cultured. 
Therefore these strains need to be investigated further before they 
are identified as the anamorphic state of N. udagawae.
The  maximal  growth  temperatures  and  MICs  of  antifungal 
agents were also examined. The maximal growth temperatures of 
clades I, II, III, IV and V were above 50 °C, 45 °C, 45 °C, 42 °C 
and 42 °C, respectively. These phenotypic data may be useful for 
classification of species within Aspergillus section Fumigati. The 
isolates of A. lentulus demonstrated lower in vitro susceptibilities 
to amphotericin B than other isolates in section Fumigati (Balajee 
et al. 2005a). In conclusion, these studies showed that species of 
Aspergillus section Fumigati were divisible into five distinct clades 
by molecular analyses. Further, results revealed good correlation 
between phylogenetic and phenotypic characteristics. Comparative 
sequence  analyses  of  the  benA  and  cal  regions  offered  good 
resolution  and  can  be  used  for  species  delimitation  within  the 
section Fumigati. 
Molecular  phylogeny  in  Aspergillus  section  Terrei 
Although A. terreus is a less common cause of invasive pulmonary 
aspergillosis when compared to A. fumigatus, infections due to 
these aspergilli appear to be increasing in frequency in certain 
hospitals worldwide (Baddley et al. 2003; Lass-Florl et al. 2000). 
Infections due to these organisms are difficult to treat because 
of both in vitro and in vivo refractoriness of the organism to the 
antifungal drug amphotericin B. In addition, A. terreus often causes 
disseminated infection with increased lethality compared with other 
Aspergillus spp. (Iwen et al. 1998; Steinbach et al. 2004; Walsh 
et al. 2003). Aspergillus terreus may be nosocomial in origin with 
potential reservoirs including construction activity, soil of potted 
plants, and water distribution systems in hospital environments 
(Lass-Florl et al. 2000; Anaissie et al. 2002; Flynn et al. 1993). In 
spite of the emerging threat due to this opportunistic pathogen, little 
is known about the genetic diversity and population structure of A. 
terreus. 
A. terreus grows on potato dextrose agar at 25 °C as beige 
to buff to cinnamon brown colonies with reverse of the colony 41 www.studiesinmycology.org
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N. aurata CBS466.65T AF057318
N. stramenia CBS498.65T AY870766
N. assulata KACC41691T DQ114123
A. unilateralis CBS126.56T AF057316
N. multiplicata CBS646.95T DQ114129
N. galapagensis IBT 16763T DQ534146
N. glabra CBS111.55T AY870734
A. turcosus KACC 42091T DQ534143
N. nishimurae IFM 53610T AB201361
N. hiratsukae NRRL20819 AF057324
N. fennelliae* MTA CBS598.74T DQ114127
N. fennelliae* MTa CBS599.74T DQ114128
N. denticulata CBS652.73T DQ114125
N. fenelliae (=N. otani IFM 54135T) AB201363
N. fenelliae (=N. otani IFM 54134T) AB201362
N. tatenoi (=N. delicata CBS101754T) DQ114124
N. tatenoi CBS407.93T DQ114130
N. spathulata MTA CBS408.89T AF057320
N. spathulata MTa CBS409.89T AF057320
N. pseudofischeri CBS208.92T AY870.742
N. quadricincta (=N. primulina CBS253.94T) AF057326
N. quadricincta CBS135.52T AF057326
A. brevipes CBS118.53T AF0572311
A. duricaulis CBS481.65T AF057313
N. udagawae CBS114217T AF132226
N. udagawae CBS114218T AF132230
N. aureola CBS105.55T AF057319
A. viridinutans* CBS127.56T AF134779
A. viridinutans (= A. fumigatus var. sclerotiorum CBS458.75T) AY685178
N. laciniosa KACC 41657T AY870756
N. spinosa (=N. botucatensis CBS114221T) AY870763
N. spinosa (=N. paulistensis CBS114216T) AY870764
N. spinosa CBS483.65T AF057329
A. fumigatiaffinis IBT12703T DQ094885
A. novofumigatus IBT16806T DQ094886
N. coreana* KACC 41659T AY870758
A. lentulus FH5T AY738513
A. fumisynnematus IFM42277T AB248076
N. fischeri CBS544.65T AF057322
A. fumigatus CBS133.61 AY685150
A. fumigatus (= var. acolumnaris) CBS457.75T AY685152
A. fumigatus (= var. ellipticus) CBS457.65T AY685149
A. fumigatus (= var. phialiseptus) CBS542.75T AY685153
A. fumigatus (= A. anomalus) CBS158.71T AY685159
A. fumigatus (albino mutant) CBS386.75 AY685168
100
100
99
99
95
98
99
86
86
85
97
79
95
86
91
62
91
94
74
62
0.01
Fig. 1. Phylogenetic tree of Aspergillus section Fumigati species inferred from Neighbour-Joining analysis of partial β-tubulin gene sequence. The shaded species have been 
reported from clinical environment.42
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appearing yellow. Microscopically, conidial heads are biseriate and 
columnar with smooth walled conidiophores; conidia are globose 
and  smooth.  Globose,  sessile,  hyaline  accessory  conidia  are 
frequently produced on submerged hyphae and are also produced 
in vivo during infection. Based on these phenotypical characteristics, 
A. terreus has been described as the only member of section Terrei 
and includes two varieties – A. terreus var. africanus and A. terreus 
var. aureus. However, molecular studies using the D1–D2 regions 
of the 28S RNA and the ITS regions (intergenic spacer regions 1 
and 2 including the 5.8S rRNA) have indicated that this section 
should be expanded to include a number of other species (Varga 
et al. 2005). Recently, a three locus phylogenetic approach using 
partial regions of the protein coding genes β-tubulin, calmodulin 
and  enolase  has  been  attempted  to  characterise  the  genetic 
variability of a large number of A. terreus isolates [Balajee et al. in 
prep.]. These results suggest that A. terreus var. aureus should be 
raised to species status and that several cryptic species probably 
exist within isolates identified as A. terreus. Interestingly, members 
of one cryptic species/clade included clinical isolates recovered 
predominantly  as  colonising  agents  in  the  immunocompetent 
population [Balajee et al. in prep.]. Although the results of this study 
demonstrated the usefulness of the three-locus sequence strategy 
for species recognition in section Terrei, comparative sequence 
analyses of the benA region alone appeared to be a good marker 
for species recognition in this section. 
Emericella species causing invasive infections
Invasive infections caused by Emericella species are uncommon 
in humans. Infections due to E. nidulans (anamorph Aspergillus 
nidulans) appear to occur predominantly in patients with chronic 
granulomatous disease (CGD), a rare disorder of phagocytes in 
which absence of superoxide and hydrogen peroxide production in 
phagocytes predisposes patients to bacterial and fungal infections. 
Invasive E. nidulans infections in this patient group are associated 
with a higher mortality than those caused by A. fumigatus (Dotis 
et al. 2003). E. nidulans is rarely encountered in other patient 
populations at risk for aspergillosis, such as those with neutropenia 
from myeloablative chemotherapy or recipients of a hematopoietic 
stem cell transplant. The lung is the most common site of infection, 
followed by subcutaneous or liver abscess, suppurative adenitis, 
osteomyelitis, fungemia, cellulitis and meningitis (van"t Hek et al. 
1998; Winkelstein et al. 2000). 
The  identification  of  E.  nidulans  in  clinical  microbiology 
laboratories is commonly based on the characteristic microscopic 
morphology.  The  conidiophore  typically  shows  metulae  and 
phialides arranged on the upper part of the flask-shaped vesicle. E. 
nidulans produces dark green conidia (asexual spores) on brown-
tinged  conidiophores,  and  characteristic  cleistothecia  contain 
asci with 8 purple-red ascospores (Fig. 3). Hülle cells, thickened 
large cells associated with cleistothecia, are often abundant in E. 
A. brevipes, A. duricaulis, A. unilateralis
A. viridinutans
N. aureola
A. fumigatiaffinis
A. novofumigatus
A. fumisynnematus
A. lentulus
A. fumigatus var. ellipticus
N. udagawae
II
IV
I
M :  Microtuberculate
L :  Labate-reticulate
M
L
M
M
L
V
A. fumigatus
Aspergillus sp. IFM 5058,  
51744, 53867, 53868, 
54302, CBM FD-143
III
I
L-M
42 ˆ
45 ˆ
42 ˆ
Maximal 
growth 
temperature
>50 ˆ
45 ˆ
M
42 ˆ
Fig. 2. Correlation among phylogeny, detailed morphology and maximal growth temperatures on Aspergillus section Fumigati. The letters L and M refer to the conidial 
ornamentation as observed by scanning electron microscopy. 43 www.studiesinmycology.org
as p e r g i l l u s Sp e c i e S id e n t i f i c at i o n in t h e cl i n i c a l Se t t i n g
nidulans. Another species within the genus Emericella that causes 
infection in humans is E. quadrilineata, which was reported to cause 
onychomycosis in one patient and sinusitis in two patients with 
hematological malignancy (Drakos et al. 1993; Gugnani et al. 2004; 
Polacheck et al. 1992). The morphologic features that distinguish 
E. nidulans from E. quadrilineata can be detected only by electron 
microscopy: the ascospores of E. nidulans have two longitudinal 
crests, while E. quadrilineata has four short equatorial crests. 
A recent cluster of infections caused by Emericella species 
involving four patients was found to be due to E. quadrilineata 
based  on  sequence-based  analysis  of  ITS1  and  ITS2  regions 
[Verweij et al. in prep.]. Morphologically, the isolates were identical 
to E. nidulans. The identification of the strains involved in the cluster 
was further confirmed to be E. quadrilineata by sequence analysis 
of partial regions of the β-tubulin and the calmodulin genes [Verweij 
et al. in prep.]. In addition, several strains from the collection of the 
Centraalbureau voor Schimmelcultures were included in the study 
as well as clinical E. nidulans and E. quadrilineata isolates from 
published cases or private culture collections (Dotis et al. 2004). 
Based  on  the  sequence-based  analysis,  several  isolates  were 
reclassified. The availability of molecular techniques in addition 
to morphological identification was shown to describe a role of E. 
quadrilineata as opportunistic fungal pathogen. The use of these 
techniques will help to identify and discriminate more accurately 
within the current fungal species and give more insight into the 
pathogenesis of fungal infection.
Pathogenic species in section Usti
A. ustus is a world-wide occurring species commonly found in food, 
soil and indoor environments (Samson et al. 2002). Aspergillus 
ustus is also isolated from clinical specimens; however, invasive 
infections caused by this species are uncommon. In the review by 
Panackal et. al. (2006), 21 documented cases of human infection 
were reported in the literature. Since this review, two more studies, 
a case of fungal endophthalmitis and a cluster of eye infections, 
have been published (Saracli et al. 2007; Yildiran et al. 2006). The 
true incidence of infections caused by this species is probably 
higher than reported, as there are cases where the fungus has 
not been identified or other instances where the organism was 
identified  but  remains  unpubl.  (Chakrabarti  et  al.  1998).  The 
mortality associated with invasive aspergillosis caused by A. ustus 
seems strikingly high – of the 22 reported cases only 6 patients 
survived. One main reason for this high mortality rate could be the 
decreased susceptibilities of A. ustus to various antifungal drugs. In 
vitro susceptibility testing showed that this species has decreased 
susceptibilities to the antifungal drugs amphotericin B, caspofungin, 
itraconazole, voriconazole and posaconazole but is susceptible to 
the allylamine terbinafine (Yildiran et al. 2006; Garcia-Martos et al. 
2005; Gene et al. 2001; Pavie et al. 2005). 
A  ustus  (Bainier)  Thom  and  Church  (1926),  described  in 
1881 by Bainier as Sterigmatocystis usta, was placed by Thom 
and Raper together with A. granulosus, in the A. ustus group. 
This group was revised by Raper and Fennell, who used a broad 
description of A. ustus and added A. puniceus, A. panamensis, 
A. conjunctus, and A. deflectus. The use of the name “groups”, 
a category without nomenclatural standing, was abandoned, and 
infrageneric taxa were formalised. Subgenera and sections were 
Fig. 3. Scanning electronmicroscopy of ascospores of Emericella species. A. E. nidulans. B. E. echinulata. C. E. quadrilineata. D. E. rugulosa. Scale bars = 5 µm.44
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created and A. ustus became the type species of section Usti, 
which was placed in the subgenus Nidulantes (Gams et al. 1985). 
Peterson  (2000)  compared  this  phenotype-based  classification 
system with the phylogenetic relationships based on the D1 and D2 
regions of the large subunit ribosomal RNA (lsu-DNA). These data 
show that the type strain of A. ustus (and therefore also the section 
Usti) was in the subgenus Nidulantes. Because the entire section 
Usti branched between Emericella species, Usti was deleted and 
placed in section Nidulantes. However, the invalidation of section 
Usti by Peterson is rejected here since multiple sections can be 
linked to one teleomorph, and since the species also form a distinct 
clade  within  the  subgenus  Nidulantes.  Based  on  the  study  of 
Peterson (2000), A. ustus, A. puniceus and A. pseudodeflectus are 
true members of the section Usti, while A. deflectus is tentatively 
placed in section Nidulantes and A. panamensis and A. conjunctus 
are in section Sparsi.
Of all the members in the section Usti, A. ustus is most often 
reported to be a causal agent of invasive infection, whereas A. 
puniceus  and  A.  pseudodeflectus  have  never  been  mentioned 
in relation with infections. Only one report in available about A. 
granulosus,  where  this  organism  was  described  as  the  causal 
agent of a disseminated infection in a cardiac transplant patient 
(Fakih et al. 1995). A MLST study using the partial regions of 
β-tubulin, calmodulin and actin genes showed that A. ustus strains 
received from multiple centers (Panackal et al. 2006; Yildiran et al. 
2006; Verweij et al. 1999) revealed the presence of a new species 
A.  calidoustus  (sp.  nov.)  from  predominantly  clinical  samples 
[Varga et. al., unpubl. data]. Phenotypic differences between A. 
ustus and A. calidoustus are easy to recognise, since the latter 
grows rapidly at 37 °C, while the former does not. Nevertheless, 
other undescribed species, which are also able to grow at 37 °C, 
are present in section Usti and the occurrence of these species 
in clinical samples remains unknown. Thus, identification solely 
based on morphology appears difficult and unreliable. An additional 
problem with members of section Usti is that these species rarely 
cause invasive infections, which makes identification even more 
difficult.  Combining  all  of  above  mentioned  details,  the  use  of 
morphology in combination with sequence data is recommended 
as an approach which will generate a less subjective and more 
reliable result.
Analyses  of  the  D1–D2  sequences  currently  deposited  in 
GenBank showed that two main clades are present in the section 
Usti. In one clade the type cultures of A. ustus (U29791; NRRL 275), 
A. puniceus (AY216673; CBS 495.65) and A. ustus var. laevis are 
present (U29788; NRRL 1852); the other clade includes the types 
of A. granulosus (AF454165; CBS 119.58) and A. pseudodeflectus 
(AF433123; NRRL 6135). However, the D1–D2 region does not 
have enough variation for species delimitation. The presence of 
these two main clades is also confirmed by a phylogenetic analysis 
of the ITS region of the ribosomal RNA (Varga et. al., unpubl. data). 
Although identification of medically important aspergilli based on 
ITS sequence data is more reliable than that based on D1–D2 data 
(Hinrikson et al. 2005), it is also known that the genetic variability 
within the ITS region is not sufficient and that some Aspergillus 
species share identical sequences. This is also the case within the 
section Usti, where A. pseudodeflectus and A. calidoustus could 
not be discriminated on ITS data alone [Varga et al. in prep.]. For 
correct species identification within this section, it is recommended 
to use the protein coding genes rather than ITS or D1–D2 data. 
Partial regions of β-tubulin, calmodulin and actin genes were tested 
and gave good resolution and are therefore excellent identification 
markers within the section Usti. 
RECOMMENDATIONS
The preceding presentations clearly demonstrate that a multi locus 
sequence identification method where multiple genes (or portions 
there of) are sequenced and the resultant data are analyzed by 
phylogenetic methods is a robust strategy for species recognition 
within the genus Aspergillus. However, this methodology involves 
significant cost and phylogenetic expertise that are limiting factors 
in most clinical microbiology laboratories. Additionally, consideration 
should also be given to the fact that most of these isolates may 
not be true causative agents of disease and therefore may not 
warrant species level identification in a diagnostic laboratory. Taken 
together, a universal single marker that would rapidly and accurately 
identify Aspergillus isolates to the species level would help support 
diagnostic microbiology laboratories in their routine identification 
efforts.  Comparative  sequence-based  methods  are  finding  a 
place  in  the  clinical  microbiology  laboratory  for  fungal  species 
identification, and there is a need for a consensus recommendation 
for such global markers that can be used with confidence for this 
purpose. 
Recently, the international group of experts that gathered for 
the workshop entitled “Aspergillus Systematics in the Genomic Era” 
reviewed research data presented from research groups worldwide 
on recent genomic investigations, secondary metabolite analyses, 
multi  locus  phylogenetic  analyses  of  the  genus  Aspergillus, 
and  sequence  based  identification  schemes  for  previously 
recognised  human  pathogens  within  the  genus.  Deriving  from 
the entire proceedings of the workshop in general and from the 
session on clinically relevant aspergilli in particular, the following 
recommendations were proposed as a first step towards formulating 
a  unified  sequence-based  identification  scheme  for  the  genus 
Aspergillus.
Although not discussed in this session, previous publications 
and research work presented elsewhere during the meeting revealed 
the utility of ITS region for identification of Aspergillus isolates to 
the section level. Thus, as a first recommendation, comparative 
sequence analyses of the ITS regions, specifically the ITS1 and 
ITS2 non-coding regions flanking the 5.8S rDNA, was suggested 
as an appropriate locus for identification of Aspergillus isolates to 
the level of subgenus/section. Use of the ITS sequence should 
be sufficient to place most isolates within the appropriate section, 
but  will  not  provide  sufficient  sensitivity  to  discriminate  among 
individual species within the section. Realising the limitations of the 
ITS regions to identify intrasection species, sequence comparison 
of the β-tubulin region for species identification within the section 
(discussed in detail throughout this manuscript) was proposed as 
the second recommendation. 
The ITS region is a convenient universal marker for fungal 
species identification and most clinical microbiology laboratories 
still rely on morphology based identification; both these strategies 
will not identify species within the sections. Considering these two 
factors and to help support species reporting in clinical microbiology 
laboratories, the term “complex” was proposed as an alternate to 
“section”. Thus, whether clinical microbiology laboratories rely on 
morphological identification methods or an ITS based sequencing 
strategy, it is advised to report species within the sections Fumigati, 
Flavi, Nidulantes, Usti and Terrei as “species complex”, for instance, 
“A. fumigatus complex”. Results reported in this manner should be 
interpreted as indicating the placement of the isolate within the 
species complex, but not necessarily indicating a species within that 
section. The microbiologist and the clinician can then jointly decide 45 www.studiesinmycology.org
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whether further DNA sequencing using a protein coding locus is 
required to identify the individual into a particular species within 
the  section/complex.  This  information  may  be  necessary  when 
investigating an outbreak, when dealing with infections refractory 
to antifungal therapy, or when performing applied epidemiologic 
studies. In all cases, communication between the clinician and the 
microbiologist is critical to provide results that benefit patient care 
with the highest value and the least cost. 
It must be remembered that these are tentative recommendations 
that are based on research data available at this time. It should 
also be reiterated that comparative sequence analyses should be 
used in tandem with morphological examination for an identification 
scheme to be successful. We believe that these recommendations 
will  help  stimulate  further  discussion,  encourage  validations  of 
appropriate loci for comparative sequence strategies, and focus 
research  studies  on  the  clinical  relevance  of  recovering  these 
species from our patient populations. 
The  contributors  to  this  session  were:  A.  Balajee,  Pathogenic 
species  in  Aspergillus  section  Terrei;  T.  Yaguchi,  Pathogenic 
species in Aspergillus subgenus Fumigati; B. Hong, Speciation in 
Aspergillus subgenus Fumigati; P. Verweij, Emericella pathogens;   
J. Houbraken, Pathogenic species in section Usti.
DISCLAIMER
The findings and conclusions in this article are those of the author(s) 
and do not necessarily represent the views of the CDC. 
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